TP53 and urinary bladder carcinoma: This result is consistent with what occurs in bladder cells after cisplatin treatment [76], which suggests that different drugs may repair the impaired miRNA biogenesis pathway in bladder cancer cells to some extent by enhancing the expression of p53-mediated miRNAs.